[HTML][HTML] The T cell immune response against SARS-CoV-2

P Moss - Nature immunology, 2022 - nature.com
The adaptive immune response is a major determinant of the clinical outcome after SARS-
CoV-2 infection and underpins vaccine efficacy. T cell responses develop early and …

[PDF][PDF] The T cell immune response against SARS-CoV-2

P Moss - sostelemedicina.ucv.ve
The adaptive immune response is a major determinant of the clinical outcome after SARS-
CoV-2 infection and underpins vaccine efficacy. T cell responses develop early and …

[PDF][PDF] The T cell immune response against SARS-CoV-2

P Moss - innermosthealthcare.com
The adaptive immune response is a major determinant of the clinical outcome after SARS-
CoV-2 infection and underpins vaccine efficacy. T cell responses develop early and …

[引用][C] The T cell immune response against SARS-CoV-2

P Moss - Nature Immunology, 2022 - cir.nii.ac.jp
The T cell immune response against SARS-CoV-2 | CiNii Research CiNii 国立情報学研究所
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

The T cell immune response against SARS-CoV-2

P Moss - Nature immunology, 2022 - pubmed.ncbi.nlm.nih.gov
The adaptive immune response is a major determinant of the clinical outcome after SARS-
CoV-2 infection and underpins vaccine efficacy. T cell responses develop early and …

The T cell immune response against SARS-CoV-2.

P Moss - Nature Immunology, 2022 - europepmc.org
The adaptive immune response is a major determinant of the clinical outcome after SARS-
CoV-2 infection and underpins vaccine efficacy. T cell responses develop early and …